Does influenza vaccination reduce major adverse cardiovascular events in high-risk patients?
High-risk patients, including individuals with recent acute coronary syndrome (ACS)
Influenza vaccination
Major adverse cardiovascular eventscomposite
Influenza vaccination is associated with a significantly lower risk of major adverse cardiovascular events, particularly in patients with recent ACS.
In this study, receipt of influenza vaccination was associated with a 34% lower risk of major adverse cardiovascular events, and individuals with recent ACS had a 45% lower risk. Given influenza poses a threat to population health during the COVID-19 pandemic, it is integral to counsel high-risk patients on the cardiovascular benefits of influenza vaccination.
Building similarity graph...
Analyzing shared references across papers
Loading...
Bahar Behrouzi
University of Toronto
Deepak L. Bhatt
Mount Sinai Health System
Christopher P. Cannon
Université Claude Bernard Lyon 1
JAMA Network Open
Harvard University
University of Toronto
Brigham and Women's Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Behrouzi et al. (Fri,) studied this question.
synapsesocial.com/papers/69d570ca75589c71d767df37 — DOI: https://doi.org/10.1001/jamanetworkopen.2022.8873